DSM-Firmenich AG (XSWX:DSFIR) EPS without NRI: CHF1.14 (TTM As of Dec. 2025)


XSWX:DSFIR DSM-Firmenich AG XSWX:DSFIR
31 GF Score
Price CHF74.82
GF Value CHF70.59
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG EPS without NRI?

DSM-Firmenich AG XSWX:DSFIR +5.62% 31 EPS without NRI is CHF1.14 as of Dec. 2025. GuruFocus rates XSWX:DSFIR with a GF Score™ of 31/100 and a GF Value™ of CHF70.59 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,261 Chemicals companies, DSM-Firmenich AG ranks worse than 70.82% on this metric.

DSM-Firmenich AG's earnings per share without non-recurring items for the six months ended in Dec. 2025 was CHF-0.68. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was CHF1.14.

During the past 12 months, DSM-Firmenich AG's average earnings per share (NRI) Growth Rate was 188.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -17.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for DSM-Firmenich AG's EPS without NRI or its related term are showing as below:

XSWX:DSFIR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -17   Med: -17   Max: -17
Current: -17

During the past 4 years, DSM-Firmenich AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -17.00% per year. The lowest was -17.00% per year. And the median was -17.00% per year.

XSWX:DSFIR's 3-Year EPS without NRI Growth Rate is ranked worse than
70.82% of 1261 companies
in the Chemicals industry
Industry Median: -1.7 vs XSWX:DSFIR: -17.00

DSM-Firmenich AG's EPS (Diluted) for the six months ended in Dec. 2025 was CHF-5.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.98.

DSM-Firmenich AG's EPS (Basic) for the six months ended in Dec. 2025 was CHF-5.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-3.98.


DSM-Firmenich AG  (XSWX:DSFIR) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


DSM-Firmenich AG EPS without NRI Related Terms


DSM-Firmenich AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG EPS without NRI Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
EPS without NRI
6.02 -2.71 1.07 3.09

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial -0.66 0.15 0.98 1.82 -0.68

XSWX:DSFIR vs LIN, SHW, ECL: EPS without NRI Comparison

For the Specialty Chemicals subindustry, DSM-Firmenich AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DSM-Firmenich AG PE Ratio without NRI vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where DSM-Firmenich AG's PE Ratio without NRI falls into.


XSWX:DSFIR
31GF Score
DSM-Firmenich AG XSWX:DSFIR
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of CHF1.14 mean?
DSM-Firmenich AG (XSWX:DSFIR) has a EPS without NRI of CHF1.14 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on DSM-Firmenich AG and its competitors. According to the industry distribution chart, DSM-Firmenich AG ranks #893 out of 1261 companies in the Chemicals industry, placing it in the top 70.8%.
Is DSM-Firmenich AG's EPS without NRI too high?
DSM-Firmenich AG's current EPS without NRI is CHF1.14. Based on the distribution chart, DSM-Firmenich AG ranks #893 out of 1261 companies in the Chemicals industry, which is below the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EPS without NRI compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #893 out of 1261 companies for EPS without NRI. This places DSM-Firmenich AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current EPS without NRI is CHF1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.59, compared to a current price of CHF74.82 — trading 6% above its estimated fair value. The current EPS without NRI is CHF1.14. DSM-Firmenich AG's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current EPS without NRI is CHF1.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of CHF74.82 is trading 6% above its estimated GF Value™ of CHF70.59. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XSWX:DSFIR:

  • EPS without NRI: CHF1.14
  • GF Value™: CHF70.59 vs. price of CHF74.82 (6% above fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score

Get the complete analysis for XSWX:DSFIR

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.82
Price
CHF70.59
GF Value